Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Addus HomeCare USD 18.66M 0 Jun/2026
Amarin USD 20.81M 13K Dec/2025
Cassava Sciences USD 48.31M 0 Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Option Care Health USD 149.78M 7.21M Jun/2026
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Tilray USD 116.52M 5.01M Sep/2025